PubMed:17897478 / 189-686 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T3","span":{"begin":0,"end":211},"obj":"Sentence"},{"id":"T4","span":{"begin":212,"end":497},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":211},"obj":"Sentence"},{"id":"T4","span":{"begin":212,"end":497},"obj":"Sentence"}],"text":"Few studies have compared treatment strategies in patients with asthma poorly controlled on low dose inhaled corticosteroids, and little is known about the effects of different treatments on airway inflammation. In this double-blind, placebo-controlled, parallel group study, we compared the effects of salmeterol plus fluticasone propionate (FP) (Seretide; SFC) and FP plus montelukast (FP/M) on sputum inflammatory markers, airway responsiveness, lung function, and symptoms in adult asthmatics."}

{"project":"PubMed_Structured_Abstracts","denotations":[{"id":"T1","span":{"begin":0,"end":497},"obj":"BACKGROUND"}],"text":"Few studies have compared treatment strategies in patients with asthma poorly controlled on low dose inhaled corticosteroids, and little is known about the effects of different treatments on airway inflammation. In this double-blind, placebo-controlled, parallel group study, we compared the effects of salmeterol plus fluticasone propionate (FP) (Seretide; SFC) and FP plus montelukast (FP/M) on sputum inflammatory markers, airway responsiveness, lung function, and symptoms in adult asthmatics."}

{"project":"PMID_GLOBAL","denotations":[{"id":"T2","span":{"begin":64,"end":70},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":449,"end":453},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0004979"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0021117"}],"text":"Few studies have compared treatment strategies in patients with asthma poorly controlled on low dose inhaled corticosteroids, and little is known about the effects of different treatments on airway inflammation. In this double-blind, placebo-controlled, parallel group study, we compared the effects of salmeterol plus fluticasone propionate (FP) (Seretide; SFC) and FP plus montelukast (FP/M) on sputum inflammatory markers, airway responsiveness, lung function, and symptoms in adult asthmatics."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":64,"end":70},"obj":"HP_0002099"},{"id":"T2","span":{"begin":227,"end":232},"obj":"HP_0000618"}],"text":"Few studies have compared treatment strategies in patients with asthma poorly controlled on low dose inhaled corticosteroids, and little is known about the effects of different treatments on airway inflammation. In this double-blind, placebo-controlled, parallel group study, we compared the effects of salmeterol plus fluticasone propionate (FP) (Seretide; SFC) and FP plus montelukast (FP/M) on sputum inflammatory markers, airway responsiveness, lung function, and symptoms in adult asthmatics."}